Similar Items: Molecular Evaluation of Interleukin-8, Interleukin-27, and Vascular Endothelial Growth Factor Expression in Prostate Cancer Patients
- Assessment of Interleukin-31 and Calprotectin in Immunocompromised Patients with Epstein-Barr Virus Infection
- Immunological Impact of Calprotectin and Interleukin-34 in Immunocompromised Patients with Chronic Cytomegalovirus Infection
- Interleukin-8 in health and disease
- Prostatic fibroblast reprogramming by Interleukin-30 activates prostate cancer metastasis programs
- Interleukin 32 Expression in Mesothelioma
- Expression of vascular endothelial growth factor in dogs with Spirocerca lupi-associated neoplastic transformation